2016 International Congress Archives - Page 64 of 207

Dorsal simultanagnosia as a cortical sign in the tauopathy spectrum

B. Bergmans, O. Deryck, R. Bruffaerts (Brugge, Belgium)
Dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behaviour disorder

R. De Marzi, K. Seppi, B. Högl, C. Müller, C. Scherfler, A. Stefani, A. Iranzo, E. Tolosa, J. Santamarìa, E. Gizewski, M. Schocke, C. Kremser, W. Poewe (Innsbruck, Austria)
Dosing of abobotulinumtoxinA and muscle selection in patients with simple patterns of cervical dystonia

V.P. Misra, R. Trosch, S. Om, P. Maisonobe (London, United Kingdom)
Double-blind, placebo-controlled trial of a fermented milk containing multiple probiotic strains and prebiotic fiber for constipation associated with Parkinson’s disease

E. Cereda, C. Pacchetti, C. Bolliri, E. Cassani, L. Iorio, C. Pusani, G. Pinelli, G. Privitera, I. Cesari, S.A. Faierman, R. Caccialanza, G. Pezzoli, M. Barichella (Pavia, Italy)
Dropped head syndrome in parkinsonism: Two treatable etiologies not to miss

P. Termsarasab, S.J. Frucht (New York, NY, USA)
Drp1 inhibition amelioratesα-synuclein-mediated neurodegeneration in rats

S. Bido, L. Arcuri, M. Helly, R. Fan, K. Tieu, E. Bezard (Bordeaux, France)
Drug induced parkinsonism: Role of functional imaging and follow up

A.S. Shetty, H.J. Shah, V.R. Lele, P.M. Wadia (Mumbai, India)
Drug safety in the pharmacotherapy of Parkinson’s disease

S. Müller-Rebstein, C. Trenkwalder, J. Ebentheuer, C. Culmsee, G. Höglinger (Kassel, Germany)
Drug-induced parkinsonism in Taiwan

J.J. Lin, K.C. Yueh, A.C. Chen (Nantou, Taiwan)
DTI in Parkinson’s disease: Asymmetric progression

L. Chan, K. Ng, C. Yeoh, H. Rumpel, E. Tan (Singapore, Singapore)